Cargando…
Cost-Effectiveness of [(18)F] Fluoroethyl-L-Tyrosine for Temozolomide Therapy Assessment in Patients With Glioblastoma
Background and Purpose: Glioblastomas are the most aggressive of all gliomas. The prognosis of these gliomas, which are classified as grade IV tumors by the World Health Organization (WHO), is poor. Combination therapy, including surgery, radiotherapy, and chemotherapy has variable outcomes and is e...
Autores principales: | Baguet, Tristan, Verhoeven, Jeroen, De Vos, Filip, Goethals, Ingeborg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722181/ https://www.ncbi.nlm.nih.gov/pubmed/31555584 http://dx.doi.org/10.3389/fonc.2019.00814 |
Ejemplares similares
-
[(18)F]-fluoroethyl-L-tyrosine (FET) in glioblastoma (FIG) TROG 18.06 study: protocol for a prospective, multicentre PET/CT trial
por: Koh, Eng-Siew, et al.
Publicado: (2023) -
New fluoroethyl phenylalanine analogues as potential LAT1-targeting PET tracers for glioblastoma
por: Verhoeven, Jeroen, et al.
Publicado: (2019) -
Quantification of O-(2-[(18)F]fluoroethyl)-L-tyrosine kinetics in glioma
por: Koopman, Thomas, et al.
Publicado: (2018) -
Glioma Imaging by O-(2-18F-Fluoroethyl)-L-Tyrosine PET and Diffusion-Weighted MRI and Correlation With Molecular Phenotypes, Validated by PET/MR-Guided Biopsies
por: Cheng, Ye, et al.
Publicado: (2021) -
Investigation of Cerebral O-(2-[(18)F]Fluoroethyl)-L-Tyrosine Uptake in Rat Epilepsy Models
por: Stegmayr, Carina, et al.
Publicado: (2020)